Hye Won Yoo

Hye Won Yoo

Auto-generated profile, based on publicly available information

Hye Won Yoo

Department of Pediatrics, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
MJMinyoung Jung
Minyoung Jung
UKUrim Kang
Urim Kang
SKSukyung Kim
Sukyung Kim
HYHye Won Yoo
Hye Won Yoo
HKHye-Young Kim
Hye-Young Kim
JKJihyun Kim
Jihyun Kim
Jung M, et al. J Korean Med Sci. 2023 Jun;38(27):e208. https://doi.org/10.3346/jkms.2023.38.e208

1 April 2022 in Asia Pacific Allergy
Verified
Journal Article
Open access
PDF file
HYHye Won Yoo
Hye Won Yoo
HKHye-Young Kim
Hye-Young Kim
KSKihyuk Shin
Kihyuk Shin
SKSeong Heon Kim
Seong Heon Kim
Background: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe adverse cutaneous reactions, most commonly triggered by medications, characterized by extensive necrosis and detachment of the epidermis. Objective: We investigated the differences in clinical characteristics of drug-induced SJS/TEN depending on the type of drug in a single center. Methods: The relevance of sex, age, culprit drugs, clinical features, courses, treatment options, and follow-up results were retrospectively evaluated in patients diagnosed with drug-induced SJS/TEN at Pusan National University Hospital between 2008 and 2019. Results: Ninety-two patients with a mean age of 58.7 ± 20.2 years (range, 10-93 years) were included in the study. Those aged 60-80 years accounted for the largest number of patients (42.4%). Patients with drug-induced SJS/TEN comprised 40 women (43.5%) and 52 men (56.5%). We categorized drug-induced SJS/TEN cases by culprit drugs into 6 groups: antibiotics, allopurinol, antiepileptic (AED), nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and other drugs. The rate of NSAID-induced disease significantly increased from SJS to TEN (p = 0.016). Among the patients in the NSAID group, the proportion of TEN (40%) was higher than that in the other groups (p = 0.021). The mean body surface area was significantly lower in the AED group than in the non-AED groups (7.1 ± 9.8 vs. 23.1 ± 27.3, p = 0.020) and higher in the NSAID group than in the non-NSAID groups (47.5 ± 39.5 vs. 15.7 ± 20.0, p = 0.010). Conclusion: This study showed that the clinical characteristics of each causative drug group may be different in drug-induced SJS/TEN. Our findings may help clinicians better understand drug-induced SJS/TEN.

1 January 2023 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
SKSukyung Kim
Sukyung Kim
MKMinji Kim
Minji Kim
JKJiwon Kim
Jiwon Kim
BPBoram Park
Boram Park
NMNuri Min
Nuri Min
JKJihyun Kim
Jihyun Kim
Kim S, et al. Allergy Asthma Immunol Res. 2023 Jan;15(1):43-54. https://doi.org/10.4168/aair.2023.15.1.43

31 March 2023 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
EYEun Hye Yang
Eun Hye Yang
HJHa Young Jo
Ha Young Jo
SPSu Jeong Park
Su Jeong Park
HYHye Won Yoo
Hye Won Yoo
SCSoo-Han Choi
Soo-Han Choi
MKMin Jung Kwak
Min Jung Kwak
Purpose: The aim of this study was to examine whether gonadotropin-releasing hormone (GnRH) agonist treatment is effective in preserving final height in patients with central precocious puberty (CPP) or early puberty (EP).Methods: The medical records of 40 patients with CPP and 206 patients with EP who completed GnRH agonist treatment following diagnosis were analyzed retrospectively. Height and height standard deviation (height SDS) scores based on bone age (BA) were measured and calculated at baseline, after treatment completion, and at final follow-up to compare changes within and between groups. Predicted adult height (PAH) was estimated by the height corresponding to height SDS for BA in girls at 18 years 11 months of age based on the growth chart.Results: PAH at baseline did not differ significantly between the CPP group (153.67±4.95) and the EP group (154.77±3.72). In the CPP group, PAH significantly increased at treatment completion (156.01±4.61) and at final follow-up (158.52±6.04) compared to baseline. In the EP group, PAH significantly increased at treatment completion (157.7±3.60) and at final follow-up (159.31±4.26) compared to baseline. The increase in PAH at all timepoints compared to baseline did not significantly differ between the CPP and EP groups.Conclusion: Both CPP and EP groups had significantly greater PAH after treatment, with no difference in the amount of increase between groups. These results show that GnRH agonist treatment can help increase final height even in patients diagnosed with EP after the age of 8 years.

31 January 2023 in Journal of Yeungnam Medical Science
Verified
Journal Article
Open access
PDF file
HJHa Young Jo
Ha Young Jo
EYEun Hye Yang
Eun Hye Yang
YKYoung Mi Kim
Young Mi Kim
SCSoo-Han Choi
Soo-Han Choi
KPKyunghee Park
Kyunghee Park
MKMin Jung Kwak
Min Jung Kwak
Background: Congenital hypothyroidism (CH) is the leading cause of preventable physical and intellectual disabilities. This study aimed to assess the incidence and clinical characteristics of CH in newborns.Methods: We retrospectively reviewed the medical records of all newborns delivered at the Pusan National University Hospital between January 2011 and March 2021. The incidence of CH was compared according to gestational age, birth weight, and small for gestational age (SGA). The patients aged ≥3 years who could not maintain normal thyroid function and required levothyroxine treatment were diagnosed with permanent CH. Logistic regression analysis was performed to compare CH risks.Results: Of 3,722 newborns, 40 were diagnosed with CH (1.07%). Gestational age and birth weight were significantly associated with CH incidence. The odds ratios (ORs) of CH in infants delivered at 32–37, 28–31, and <28 weeks were 2.568 (95% confidence interval [CI], 1.141–5.778), 5.917 (95% CI, 2.264–15.464), and 7.441 (95% CI, 2.617–21.159) times higher, respectively, than those delivered at term. The ORs of CH in infants weighing 1,500–2,499 g, 1,000–1,499 g, and <1,000 g were 4.664 (95% CI, 1.928–11.279), 11.076 (95% CI, 4.089–29.999), and 12.544 (95% CI, 4.350–36.176) times greater, respectively, than those in infants weighing ≥2,500 g. The OR of CH was 6.795 (95% CI, 3.553–13.692) times greater in SGA than in non-SGA infants.Conclusion: The CH incidence in South Korea has increased significantly compared with that in the past. Gestational age, birth weight, and SGA were significantly associated with CH incidence.

30 December 2020 in Pediatric Emergency Medicine Journal
Verified
Journal Article
Open access
PDF file
YHYosub Hwang
Yosub Hwang
HJHa Young Jo
Ha Young Jo
HYHye Won Yoo
Hye Won Yoo
YKYoung Mi Kim
Young Mi Kim
HKHye-Young Kim
Hye-Young Kim
Purpose: Trauma is the leading cause of death and disability in children. We aimed to compare the clinical characteristics of children with trauma and disease. Methods: We reviewed the medical records of children (< 19 years) who visited the emergency department of Pusan National University Hospital from 2016 through 2018. Data on the age, age group, sex, details of trauma or disease, severe trauma or disease (Korean Triage Acuity Scale 1-2), hospitalization rate (overall and intensive care unit [ICU]), hospital length of stay, in-hospital mortality, and the Injury Severity Score were compared between the children with trauma and those with disease. Results: In a total of 10,205 children, 3,028 (29.7%) had trauma. The children with trauma were older than those with disease (median age, 78.5 months [interquartile range, 35.0-165.0] vs. 49.0 [16.0-120.0]; P < 0.001). Boys were more common in the former group than the latter (63.7% vs. 56.3%; P < 0.001). The most common injury mechanism was traffic accident (16.0%), followed by fall and foreign body. The overall hospitalization rate was higher in the children with disease (17.1% vs. 35.9%; P < 0.001). However, the children with trauma underwent more frequent ICU hospitalization, and showed higher in-hospital mortality rate and longer hospital length of stay than those with disease (all P < 0.001). The children with severe trauma showed higher median age, percentage of boys, in-hospital mortality, and ICU hospitalization rate, and longer hospital length of stay than those with severe disease (all P < 0.001). Conclusion: Children with trauma tend to be older, and their condition may be more critical in severity than those with disease. This difference is more prominent in those with severe trauma or disease.